Brief: Trevi Therapeutics Q2 Net Income USD -17.797 Million
06/08/2026 21:06
BRIEF-Trevi Therapeutics Q2 Net Income USD -17.797 Million Aug 06 (Reuters) - Trevi Therapeutics Q2 income from operations USD -20.509 million.
- Q2 pretax profit USD -17.816 million
- Q2 operating expenses USD 20.509 million
- Q2 EPS USD -0.11
Recent news on Trevi Therapeutics
See all newsTrevi Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Trevi Therapeutics Q2 net loss widens on higher R&D costs
Brief: Trevi Therapeutics Q2 Net Income USD -17.797 Million
Trevi Therapeutics Q1 net loss widens as R&D costs rise
Brief: Trevi Therapeutics Q1 Net Income USD -13.192 Million